Europe Hypophosphatasia Treatment Market

List of Tables

Europe hypophosphatasia treatment market is expected to reach USD 212.72 million by 2031, from USD 163.73 million in 2023 growing at the CAGR of 3.8% in the forecast period of 2024 to 2031.

Market Segmentation

Europe Hypophosphatasia Treatment Market, By Types (Odontohypophosphatasia, Pseudohypophosphatasia, and Others), Therapy Type (Enzyme Replacement Therapy and Supportive Therapy), Route of Administration (Injectable and Oral), End User (Hospitals, Speciality Clinics, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (Germany, U.K., France, Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, and rest of Europe) - Industry Trends and Forecast to 2031

Overview of Europe Hypophosphatasia Treatment Market Dynamics

Drivers
Increasing incidence rate for hypophosphatasia
Continuous increase in clinical trials and pipeline products
Favorable reimbursement policies
Restraints
High cost of treatment
Complex treatment regimen
Opportunities
Increasing adoption of various types of advanced therapy
Initiatives by the government to create awareness
Challenges
Impact of discontinuation of drug treatment and related adverse effect
Genetic variability and disease complexity

Market Players

The key market players for Europe hypophosphatasia treatment market are listed below:

AstraZeneca
Pfizer Inc.
Abbott
Novartis AG
AM-Pharma B.V.
Be Biopharma
PuREC
Rallybio
Rampart Bioscience, Inc.
Roivant Sciences Ltd.

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE HYPOPHOSPHATASIA TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 STRATEGIC DECISIONS
4.4 PATENT ANALYSIS
4.5 PRODUCT SALES BY YEAR

5 EUROPE HYPOPHOSPHATASIA (HPP) TREATMENT MARKET: REGULATIONS

5.1 U.S. REGULATORY SCENARIO FOR HYPOPHOSPHATASIA (HPP) TREATMENT
5.2 EUROPE REGULATORY SCENARIO FOR HYPOPHOSPHATASIA (HPP) TREATMENT
5.3 INDIA
5.4 MIDDLE EAST AND AFRICA

6 MARKET OVERVIEW

6.1 DRIVERS
- 6.1.1 INCREASING INCIDENCE RATE FOR HYPOPHOSPHATASIA
- 6.1.2 CONTINUOUS INCREASE IN CLINICAL TRIALS AND PIPELINE PRODUCTS
- 6.1.3 FAVOURABLE REIMBURSEMENT POLICIES
6.2 RESTRAINTS
- 6.2.1 HIGH COST OF TREATMENT
- 6.2.2 COMPLEX TREATMENT REGIMEN
6.3 OPPORTUNITIES
- 6.3.1 INCREASING ADOPTION OF VARIOUS TYPES OF ADVANCED THERAPY
- 6.3.2 INITIATIVES BY THE GOVERNMENT TO CREATE AWARENESS
6.4 CHALLENGES
- 6.4.1 IMPACT OF DISCONTINUATION OF DRUG TREATMENT AND RELATED ADVERSE EFFECT
- 6.4.2 GENETIC VARIABILITY AND DISEASE COMPLEXITY

7 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES

7.1 OVERVIEW
7.2 ODONTOHYPOPHOSPHATASIA
7.3 PSEUDOHYPOPHOSPHATASIA
7.4 OTHERS

8 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE

8.1 OVERVIEW
8.2 ENZYME REPLACEMENT THERAPY
8.3 SUPPORTIVE THERAPY

9 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

9.1 OVERVIEW
9.2 INJECTABLE
9.3 ORAL

10 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW
10.2 HOSPITAL PHARMACY
10.3 RETAIL PHARMACY
10.4 ONLINE PHARMACY

11 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER

11.1 OVERVIEW
11.2 HOSPITALS
11.3 SPECIALTY CLINICS
11.4 OTHERS

12 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION

12.1 EUROPE
- 12.1.1 GERMANY
- 12.1.2 U.K.
- 12.1.3 FRANCE
- 12.1.4 ITALY
- 12.1.5 SPAIN
- 12.1.6 BELGIUM
- 12.1.7 RUSSIA
- 12.1.8 NETHERLANDS
- 12.1.9 TURKEY
- 12.1.10 SWITZERLAND
- 12.1.11 REST OF EUROPE

13 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 ASTRAZENECA
- 15.1.1 COMPANY SNAPSHOT
- 15.1.2 REVENUE ANALYSIS
- 15.1.3 COMPANY SHARE ANALYSIS
- 15.1.4 PRODUCT PORTFOLIO
- 15.1.5 RECENT DEVELOPMENT
15.2 PFIZER INC.
- 15.2.1 COMPANY SNAPSHOT
- 15.2.2 REVENUE ANALYSIS
- 15.2.3 COMPANY SHARE ANALYSIS
- 15.2.4 PRODUCT PORTFOLIO
- 15.2.5 RECENT DEVELOPMENTS
15.3 ABBOTT
- 15.3.1 COMPANY SNAPSHOT
- 15.3.2 REVENUE ANALYSIS
- 15.3.3 COMPANY SHARE ANALYSIS
- 15.3.4 PRODUCT PORTFOLIO
- 15.3.5 RECENT DEVELOPMENTS
15.4 NOVARTIS AG
- 15.4.1 COMPANY SNAPSHOT
- 15.4.2 REVENUE ANALYSIS
- 15.4.3 COMPANY SHARE ANALYSIS
- 15.4.4 PRODUCT PORTFOLIO
- 15.4.5 RECENT DEVELOPMENT
15.5 AM-PHARMA B.V.
- 15.5.1 COMPANY SNAPSHOT
- 15.5.2 COMPANY SHARE ANALYSIS
- 15.5.3 PRODUCT PORTFOLIO
- 15.5.4 RECENT DEVELOPMENT
15.6 BE BIOPHARMA
- 15.6.1 COMPANY SNAPSHOT
- 15.6.2 PRODUCT PORTFOLIO
- 15.6.3 RECENT DEVELOPMENT
15.7 PUREC.
- 15.7.1 COMPANY SNAPSHOT
- 15.7.2 PRODUCT PORTFOLIO
- 15.7.3 RECENT DEVELOPMENT
15.8 RALLYBIO
- 15.8.1 COMPANY SNAPSHOT
- 15.8.2 PRODUCT PORTFOLIO
- 15.8.3 RECENT DEVELOPMENTS
15.9 RAMPART BIOSCIENCE, INC.
- 15.9.1 COMPANY SNAPSHOT
- 15.9.2 PRODUCT PORTFOLIO
- 15.9.3 RECENT DEVELOPMENT
15.10 ROIVANT SCIENCES LTD.
- 15.10.1 COMPANY SNAPSHOT
- 15.10.2 PRODUCT PORTFOLIO
- 15.10.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

TABLE 1 VARIOUS ASPECTS OF HYPOPHOSPHATASIA (HPP)
TABLE 2 TARGETED TREATMENT OF HYPOPHOSPHATASIA
TABLE 3 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND)
TABLE 4 EUROPE ODONTOPHOSPHATASIA IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 5 EUROPE PSEUDOPHOSPHATASIA IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 6 EUROPE OTHERS IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 7 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 EUROPE ENZYME REPLACEMENT THERAPY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 9 EUROPE SUPPORTIVE THERAPY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 10 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND)
TABLE 11 EUROPE INJECTABLE IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 12 EUROPE ORAL IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 13 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 14 EUROPE HOSPITAL PHARMACY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 EUROPE RETAIL PHARMACY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 16 EUROPE ONLINE PHARMACY IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY END-USER, 2022-2031 (USD THOUSAND)
TABLE 18 EUROPE HOSPITALS IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 EUROPE SPECIALTY CLINICS IN HYPOPHOSPHATASIA TREATMENTMARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 EUROPE OTHERS IN HYPOPHOSPHATASIA TREATMENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND )
TABLE 22 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 23 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 24 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 25 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 26 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 27 GERMANY HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 28 GERMANY HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 29 GERMANY HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 30 GERMANY HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 31 GERMANY HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 32 U.K. HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 33 U.K. HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 34 U.K. HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 35 U.K. HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 36 U.K. HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 37 FRANCE HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 38 FRANCE HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 39 FRANCE HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 40 FRANCE HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 41 FRANCE HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 42 ITALY HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 43 ITALY HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 44 ITALY HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 45 ITALY HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 46 ITALY HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 47 SPAIN HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 48 SPAIN HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 49 SPAIN HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 50 SPAIN HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 51 SPAIN HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 52 BELGIUM HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 53 BELGIUM HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 54 BELGIUM HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 55 BELGIUM HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 56 BELGIUM HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 57 RUSSIA HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 58 RUSSIA HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 59 RUSSIA HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 60 RUSSIA HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 61 RUSSIA HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 62 NETHERLANDS HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 63 NETHERLANDS HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 64 NETHERLANDS HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 65 NETHERLANDS HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 66 NETHERLANDS HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 67 TURKEY HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 68 TURKEY HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 69 TURKEY HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 70 TURKEY HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 71 TURKEY HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 72 SWITZERLAND HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )
TABLE 73 SWITZERLAND HYPOPHOSPHATASIA TREATMENT MARKET, BY THERAPY TYPE, 2022-2031 (USD THOUSAND )
TABLE 74 SWITZERLAND HYPOPHOSPHATASIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD THOUSAND )
TABLE 75 SWITZERLAND HYPOPHOSPHATASIA TREATMENT MARKET, BY END USER, 2022-2031 (USD THOUSAND )
TABLE 76 SWITZERLAND HYPOPHOSPHATASIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND )
TABLE 77 REST OF EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES, 2022-2031 (USD THOUSAND )

LIST OF FIGURES

FIGURE 1 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: SEGMENTATION
FIGURE 2 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: SEGMENTATION
FIGURE 11 SEGMENTS COMPRISE THE EUROPE HYPOPHOSPHATASIA TREATMENT MARKET, BY TYPES
FIGURE 12 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET : EXECUTIVE SUMMARY
FIGURE 13 INCREASING DIAGNOSIS FOR HYPOPHOSPHATASIA IS DRIVING THE GROWTH OF THE EUROPE HYPOPHOSPHATASIA TREATMENT MARKET FROM 2024 TO 2031
FIGURE 14 THE TYPES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE HYPOPHOSPHATASIA TREATMENT MARKET IN 2024 AND 2031
FIGURE 15 DRIVERS, RESTRIANTS, OPPORTUNITIES, AND CHALLENGES OF HYPOPHOSPHATASIA TREATMENT MARKET
FIGURE 16 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY TYPES, 2023
FIGURE 17 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY TYPES, 2024-2031 (USD THOUSAND)
FIGURE 18 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY TYPES, CAGR (2024-2031)
FIGURE 19 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY TYPES, LIFELINE CURVE
FIGURE 20 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY THEREPY TYPE, 2023
FIGURE 21 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY THEREPY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 22 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY THEREPY TYPE, CAGR (2024-2031)
FIGURE 23 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY THEREPY TYPE, LIFELINE CURVE
FIGURE 24 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2023
FIGURE 25 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2024-2031 (USD THOUSAND)
FIGURE 26 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2024-2031)
FIGURE 27 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 28 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 29 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 30 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 31 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 32 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY END USER, 2023
FIGURE 33 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 34 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY END USER, CAGR (2024-2031)
FIGURE 35 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: SNAPSHOT (2023)
FIGURE 37 EUROPE HYPOPHOSPHATASIA TREATMENT MARKET: COMPANY SHARE 2023 (%)